Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60

United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$7.60M

$5.49M on a plan · $2.11M straight out of an exercise

Sold at will

$0.00

0 of 35 sales

Net

−$7.60M

$0.00 against sales at will